Purdue and Sackler family agree to $7.4bn national opioid settlement
Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in fuelling the opioid epidemic in the country.
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a ...
Pennsylvania expects to receive $212 million over 15 years as part of a multi-state settlement with the Sackler family, who ...
The individuals behind Purdue Pharma’s involvement in the U.S. opioid crisis reached a $7-billion settlement in January 2025.
Hosted on MSN20h
New $7.4B Sackler Deal Has Unusual ConditionA new settlement has been reached on lawsuits against Oxycontin maker Purdue Pharma and the Sackler family that owns it, seven months after the Supreme Court rejected a $6 billion deal. The $7.4 ...
The agreement, announced Thursday, would require the Sackler family to pay $6.5 billion over the next 15 years and an additional nearly $900 million from Purdue Pharma following its emergence from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback